Videos

Getting on with it: How a big US supplements maker adapts to major EU law changes

04-Jun-2013 - US-based foods and supplements manufacturer, Now International, hasn’t sat on its hands since the EU’s new health claim laws kicked into play in 2008 – taking pre-emptive action to keep abreast of the new formulation and health claims landscape.

Roquette outsources lab to food supplements makers

29-May-2013 - French supplier Roquette is putting its R&D supplements facility up for rent by any party seeking to develop food supplements and food products – whether they are its own customers or not.

IADSA chair spells out global GMP progress

28-May-2013 - Quality control in the food supplements sector is an ongoing mission that remains top of the agenda at the group that most prominently represents both global and national players – IADSA - especially as new regions adopt GMP rules for the first time.

Time for mandatory folic acid fortification to go truly global?

24-May-2013 - Food fortification with neural tube defect (NTD)-reducing folic acid is mandatory in 75 nations, but concerns over cancer and other health issues mean Europe lags far behind  – a situation that needs to change and quickly, says DSM thinktank, sightandlife.

In vitro data still has an important place in EFSA dossiers, says expert

23-May-2013 - Industry must not drop interest in mechanism focused, lab-based, in vitro studies in favour of chasing human trial data, according to Dr Charles Czank of Leatherhead Food Research who argues that both in vitro and in vivo data are vital for a health claim.

EFSA sets standard for study rigor, consultant says

22-May-2013 - Differing regulatory environments can play havoc with a company's research plans, say consultant Joerg Gruenwald, PhD.  But recent, sometimes bitter, experience with the European Food Safety Authority has shed some light on how to negotiate this tangle, he said.

System of embargoing press releases skews perception of nutrition studies, GOED chief says

21-May-2013 - Recent research results about the effectiveness of omega 3 fatty acids in the prevention of secondary heart attacks have been generalized to cast doubt on the value of the ingredients' overall effectiveness in cardiovascular health.  This is unfortunate, says Adam Ismail, global director of the Global Association of EPA and DHA Omega 3s (GOED).

GMO ingredients can form part of Omega-3 supply picture, GOED chief says

20-May-2013 - Genetic modification of oil seed crops will form an important part of the future omega-3s supply picture, according to Adam Ismail, executive director of the Global Organization of EPA and DHA Omega-3s (GOED). 

New science, dosage form drives vitamin K2 interest, NattoPharma CEO says

17-May-2013 - New research results are driving interest in vitamin K2, according to NattoPharma CEO Hogne Vik.  But the company has also developed a new, more potent powder form that is helping to raise the ingredient's profile.

Trend-spotter: The rise of slow-energy

17-May-2013 - There are two speeds when it comes to energy products: Slow and fast, says Mintel trend-spotting guru David Jago.

Delivering on the personalized nutrition promise

16-May-2013 - Personalized nutrition has been the Holy Grail of nutrition science.  Dilip Ghosh, PhD, tells how the industry is getting closer to delivering on the promises that this approach implies.

Global healthcare systems are failing; nutrition policy needs to change now, says leading academic

16-May-2013 - Nations and populations are in peril of being swamped by the cost of their healthcare systems unless a severe nutrition policy rethink can occur, says a leading academic.

Happy holidays from William Reed Business Media!

19-Dec-2012 - The working year is almost done, time to pause from ‘the business’ and embrace the festive season…go on, give it a big hug. Happy holidays!

New models hold promise for probiotic claim substantiation

29-Nov-2012 - Exposing healthy people to modified pathogens in a controlled clinical trial setting could be an exciting new way for industry to overcome the challenges of health claim substantiation, says Nizo Food Research expert.

‘Huge’ opportunities in the emerging cognitive health market: Enzymotec USA CEO

21-Nov-2012 - The cognitive health sector offers huge opportunities for dietary supplements, but it’s still evolving, says the CEO of Enzymotec USA.

Low barriers of entry have enabled ‘grifters, cobblers, and vermin’ to give industry bad GMP compliance press: BI chief

21-Nov-2012 - The industry’s big names have been complying with GMP regulations for years, but low barriers to entry have made it easy for less serious companies to do business with low GMP compliance, says the chief of BI Nutraceuticals.

DuPont on EU probiotic health claim ban: “Mention specific strains”

21-Nov-2012 - Giant of probiotic supply, DuPont, is not afraid to admit its European business has been altered by the rejection of probiotic health claims under the EU nutrition and health claims regulation (NHCR).

'You can feel the difference in half an hour...' PLT on why Zembrin could be a blockbuster

20-Nov-2012 - One of the most interesting new product launches at Supply Side West last week was stress-buster Zembrin, the first patented, standardized and clinically studied extract of Sceletium tortuosum, a succulent plant known by the San people of South Africa as ‘Kanna’.

Demographics will continue to drive cardiovascular category growth: ENI President

20-Nov-2012 - The cardiovascular health segment is here to stay, with the surge in product demand by baby boomers ensuring that growth will continue, says Cal Bewicke, president of Ethical Naturals Inc.

GMP compliance levels are ‘all over the place’: Alkemists CEO

20-Nov-2012 - Current compliance levels to good manufacturing practice (cGMP) are ‘all over the place’, but ‘for the most part there is an increase in compliance’, says the CEO of Alkemists Laboratories.